Soho Global Health Tbk PT
IDX:SOHO
Soho Global Health Tbk PT
Research & Development
Soho Global Health Tbk PT
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Soho Global Health Tbk PT
IDX:SOHO
|
Research & Development
-Rp24.3B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
|
T
|
Tempo Scan Pacific Tbk PT
IDX:TSPC
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Kalbe Farma Tbk PT
IDX:KLBF
|
Research & Development
-Rp727.1B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-2%
|
|
|
Darya-Varia Laboratoria Tbk PT
IDX:DVLA
|
Research & Development
-Rp30.5B
|
CAGR 3-Years
10%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
|
Pyridam Farma Tbk PT
IDX:PYFA
|
Research & Development
-Rp28.2B
|
CAGR 3-Years
-42%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Kimia Farma Tbk PT
IDX:KAEF
|
Research & Development
-Rp22.6B
|
CAGR 3-Years
35%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-5%
|
|
Soho Global Health Tbk PT
Glance View
PT SOHO Global Health engages in the provision of healthcare services. The company is headquartered in Jakarta, Dki Jakarta and currently employs 2,373 full-time employees. The company went IPO on 2020-09-08. The firm operates through five segments: Distribution, Professional product, Consumer health, Alliance and Others. Its brands include Curcuma Plus, Curcuma Plus Milk, Imboost, Fitkom, Diapet, Laxing, Lelap, Asthma Soho and Sohobion. Curcuma Plus is a kid’s multivitamin that contains curcuma and fish oil. Curcuma Plus Milk is a growing up milk for kids. Imboost is a supplement that supports immune system. Fitkom offers kids multivitamins in gummy and tablet format. Diapet is an anti-diarrheal medicine. Laxing is a medicine for healthy digestion and bowel movement. Lelap is a medicine to alleviate sleep disorders. Asthma Soho is an asthma remedy. Sohobion is a neurotropic vitamin supplement to maintain neurological health. Its product portfolio ranged from wound care, hospital general care, surgery, orthopedics and in-vitro diagnostics.
See Also
What is Soho Global Health Tbk PT's Research & Development?
Research & Development
-24.3B
IDR
Based on the financial report for Dec 31, 2024, Soho Global Health Tbk PT's Research & Development amounts to -24.3B IDR.
What is Soho Global Health Tbk PT's Research & Development growth rate?
Research & Development CAGR 5Y
-11%
Over the last year, the Research & Development growth was -12%. The average annual Research & Development growth rates for Soho Global Health Tbk PT have been -3% over the past three years , -11% over the past five years .
